J Downs, MD
Colon & Rectal Surgery · Dallas, TXNPI 1811922610
Payments from drug & device makers
What this record shows
22 manufacturers reported payments, led by Intuitive Surgical at 54.1% of the total. Reporting peaked in 2020 at $1,736 and has fallen 91.6% since, to $145 in 2025. That places this record below the midpoint for colon & rectal surgery clinicians in TX, where the typical reported total is $4,072.
Across 52 payments — averaging $73.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- THD America, Inc.$939
- Johnson & Johnson$151
- AbbVie$138
- Sirtex Medical Inc$116
- Davol Inc.$46
- plus $372 from 16 others
What the payments were for
- Travel & lodging$1,80847%
- Food & beverage$2,02653%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 11 | $2,072 |
| THD America, Inc. | 13 | $939 |
| Johnson & Johnson | 4 | $151 |
| AbbVie(2 entities) | 6 | $138 |
| Sirtex Medical Inc | 1 | $116 |
| Davol Inc. | 1 | $46 |
| Conmed Corporation | 1 | $45 |
| Stryker | 1 | $45 |
| Innovation Technologies Inc | 1 | $28 |
| Axonics, Inc. | 1 | $25 |
| Shire North American Group Inc | 1 | $24 |
| TELA Bio, Inc. | 1 | $24 |
| Next Science LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Medtronic | 1 | $22 |
| BD | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Prescient Surgical | 1 | $16 |
| Heron Therapeutics, Inc. | 1 | $16 |
| Vertex | 1 | $16 |
| AstraZeneca | 1 | $13 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,834 in reported general payments places this provider in the 45th percentile of 200 colon & rectal surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Budesonide DrBudesonide | 12 | $1,819 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Dallas
- Robert JacobsonDallas$125K
- Katerina WellsDallas$83K
- Anand LodhaDallas$40K
- Roberto Rodriguez-RuesgaDallas$38K
- Michael PendolaDallas$21K
- Anthony MacalusoDallas$20K
- Sarah StringfieldDallas$19K
- Zachary RobertsDallas$17K
- Edward FrankoDallas$13K
- Lai XueDallas$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.